National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
   
 
Results: 1 -5 of 5         results per page
View Search Criteria | Help With Results
           
Last Modified: 10/15/2008     First Published: 5/11/2006  

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Supportive care, Treatment


Active


18 and over


NCI


RTOG-0518
0518, RTOG-0518, NCT00329797

Last Modified: 10/13/2008     First Published: 8/13/2006  

2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Supportive care


Active


18 and over


NCI


RTOG-0517
RTOG 0517, RTOG-0517, NCT00365105


3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Supportive care, Treatment


Active


18 and over


Other


ID03-0124
NCT00452439

Last Modified: 9/3/2008     First Published: 4/21/2006  

4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Supportive care, Treatment


Active


18 and over


NCI, Pharmaceutical / Industry


UMN-2005NT018
UMN-0506M70866, UMN-MT2005-06, NOVARTIS-CZOL446EUS29, NCT00321932

Last Modified: 10/2/2007     First Published: 12/21/2006  

5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Natural history/Epidemiology, Supportive care, Treatment


Active


18 and over


NCI, Pharmaceutical / Industry


UWCC-6346
NOVARTIS-UWCC-6346, UWCC-06-2386-H/A, FHCRC-6346, NCT00416715

   
   

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov